IKNA
Price:
$1.66
Market Cap:
$80.11M
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts...[Read more]
Industry
Biotechnology
IPO Date
2021-03-26
Stock Exchange
NASDAQ
Ticker
IKNA
According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.31M. This represents a change of 73.02% compared to the average of 25.03M of the last 4 quarters.
The mean historical Enterprise Value of Ikena Oncology, Inc. over the last ten years is 593.60M. The current 43.31M Enterprise Value has changed 629.65% with respect to the historical average. Over the past ten years (40 quarters), IKNA's Enterprise Value was at its highest in in the March 2020 quarter at 529.68M. The Enterprise Value was at its lowest in in the March 2021 quarter at -164603042.00.
Average
593.60M
Median
605.42M
Minimum
-26937890.43
Maximum
1.19B
Discovering the peaks and valleys of Ikena Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 1.19B
Minimum Annual Increase = -164.08%
Minimum Annual Enterprise Value = -26937890.43
Year | Enterprise Value | Change |
---|---|---|
2023 | -26937890.43 | -164.08% |
2022 | 42.04M | -81.39% |
2021 | 225.90M | -77.06% |
2020 | 984.93M | -13.91% |
2019 | 1.14B | -4.00% |
The current Enterprise Value of Ikena Oncology, Inc. (IKNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
80.33M
5-year avg
473.99M
10-year avg
593.60M
Ikena Oncology, Inc.’s Enterprise Value is less than Edgewise Therapeutics, Inc. (2.63B), less than Design Therapeutics, Inc. (319.85M), greater than Xilio Therapeutics, Inc. (-7567185.00), less than Eliem Therapeutics, Inc. (0), less than Monte Rosa Therapeutics, Inc. (396.71M), greater than Werewolf Therapeutics, Inc. (-9845928.00), less than Stoke Therapeutics, Inc. (504.84M), greater than Anebulo Pharmaceuticals, Inc. (34.64M), less than Celcuity Inc. (552.80M), less than MediciNova, Inc. (264.65M), less than Rezolute, Inc. (260.47M), less than Aerovate Therapeutics, Inc. (43.34M), less than Decibel Therapeutics, Inc. (102.82M), less than Foghorn Therapeutics Inc. (302.72M), greater than Shattuck Labs, Inc. (17.07M), less than Kymera Therapeutics, Inc. (2.71B), less than Nurix Therapeutics, Inc. (1.38B),
Company | Enterprise Value | Market cap |
---|---|---|
2.63B | $2.67B | |
319.85M | $347.65M | |
-7567185.00 | $45.28M | |
0 | $342.68M | |
396.71M | $478.59M | |
-9845928.00 | $76.20M | |
504.84M | $652.55M | |
34.64M | $36.05M | |
552.80M | $468.20M | |
264.65M | $104.96M | |
260.47M | $268.86M | |
43.34M | $73.92M | |
102.82M | $123.37M | |
302.72M | $321.33M | |
17.07M | $57.29M | |
2.71B | $2.73B | |
1.38B | $1.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ikena Oncology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ikena Oncology, Inc. (IKNA)?
What is the 3-year average Enterprise Value for Ikena Oncology, Inc. (IKNA)?
What is the 5-year average Enterprise Value for Ikena Oncology, Inc. (IKNA)?
How does the current Enterprise Value for Ikena Oncology, Inc. (IKNA) compare to its historical average?